| Dallin Brady Low, MD | |
|
3601 4th St, Lubbock, TX 79430-0002 | |
| (806) 743-1000 | |
| Not Available |
| Full Name | Dallin Brady Low |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 3601 4th St, Lubbock, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093452435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | U7004 (Texas) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Entity Name | Lubbock County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487993630 PECOS PAC ID: 6709028954 Enrollment ID: O20130819000007 |
News Archive
The National Alzheimer's Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan's biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
Researchers have identified a potential way to manipulate the immune system to improve its ability to fight off tuberculosis.
Chronix Biomedical today announced that it has completed a Series E financing that raised $1.8 million from existing and new investors. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. Chronix's serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.
The Houston Chronicle on Saturday examined the Baylor College of Medicine's International Pediatric AIDS Initiative in Bobo-Dioulasso, Burkina Faso.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dallin Brady Low, MD 3601 4th St, Lubbock, TX 79430-0002 Ph: (806) 743-1000 | Dallin Brady Low, MD 3601 4th St, Lubbock, TX 79430-0002 Ph: (806) 743-1000 |
News Archive
The National Alzheimer's Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan's biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
Researchers have identified a potential way to manipulate the immune system to improve its ability to fight off tuberculosis.
Chronix Biomedical today announced that it has completed a Series E financing that raised $1.8 million from existing and new investors. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. Chronix's serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.
The Houston Chronicle on Saturday examined the Baylor College of Medicine's International Pediatric AIDS Initiative in Bobo-Dioulasso, Burkina Faso.
› Verified 4 days ago